Inventor · disambiguated record
Benoit Christophe Stephan Callendret
Also filed as: CALLENDRET BENOIT · CALLENDRET BENOIT CHRISTOPHE STEPHAN
13 granted patents·7 pending applications·54 citations·filing 2004–2022
88Inventor score
Files withJANSSEN VACCINES & PREVENTION BV11BAVARIAN NORDIC AS4BARAS BENOIT2PASTEUR INSTITUT2VAN DER WERF SYLVIE1
Top patents by PatentIndex Score
20 records- 0191US11229695B2Method for the safe induction of immunity against RSVJANSSEN VACCINES & PREVENTION BV·Filed 2018·Granted Jan 25, 2022·8 cites·11 claims
- 0290US8343718B2Strain of SARS-associated coronavirus and applications thereofPASTEUR INSTITUT·Filed 2010·Granted Jan 1, 2013·22 cites·8 claims
- 0385US10369214B2Synthetic human immunodeficiency virus (HIV) envelope antigen, vectors, and compositions thereofJANSSEN VACCINES & PREVENTION BV·Filed 2016·Granted Aug 6, 2019·5 cites·51 claims
- 0481US7736850B2Strain of SARS-associated coronavirus and applications thereofPASTEUR INSTITUT·Filed 2004·Granted Jun 15, 2010·18 cites·5 claims
- 0572US11918639B2Methods and compositions for inducing protective immunity against filovirus infectionBAVARIAN NORDIC AS·Filed 2021·Granted Mar 5, 2024·0 cites·10 claims
- 0671US11896663B2Immunodeficiency virus type 1 (HIV-1) mutant envelope proteinsJANSSEN VACCINES & PREVENTION BV·Filed 2021·Granted Feb 13, 2024·0 cites·6 claims
- 0770US11173201B2Methods and compositions for inducing protective immunity against filovirus infectionBAVARIAN NORDIC AS·Filed 2019·Granted Nov 16, 2021·0 cites·8 claims
- 0870US10973907B2Recombinant adenoviruses encoding mosaic human immunodeficiency virus (HIV) Env, Gag, and Pol antigensJANSSEN VACCINES & PREVENTION BV·Filed 2019·Granted Apr 13, 2021·0 cites·15 claims
- 0966US2022133878A1Method for the safe induction of immunity against rsvJANSSEN VACCINES & PREVENTION BV·Filed 2022·Application pending·0 cites
- 1064US10561722B2Methods and compositions for enhancing immune responsesBAVARIAN NORDIC AS·Filed 2015·Granted Feb 18, 2020·1 cites·20 claims
- 1155US2022273787A1Co-administration of seasonal influenza vaccine and an adenovirus based respiratory syncytial virus vaccineJANSSEN VACCINES & PREVENTION BV·Filed 2020·Application pending·0 cites
- 1255US2022193219A1Prophylactic treatment of respiratory syncytial virus infection with an adenovirus based vaccineJANSSEN VACCINES & PREVENTION BV·Filed 2020·Application pending·0 cites
- 1353US2023233661A1Vaccine combination against repiratory syncytial virus infectionJANSSEN VACCINES & PREVENTION BV·Filed 2021·Application pending·0 cites
- 1451US10561721B2Methods and compositions for inducing protective immunity against filovirus infectionBAVARIAN NORDIC AS·Filed 2015·Granted Feb 18, 2020·0 cites·12 claims
- 1549US2010233250A1VaccineBARAS BENOIT·Filed 2008·Application pending·0 cites
- 1646US2012082693A1Use of proteins and peptides encoded by the genome of a novel sars-associated coronavirus strainVAN DER WERF SYLVIE·Filed 2011·Application pending·0 cites
- 1742US2012045469A1VaccineBARAS BENOIT·Filed 2009·Application pending·0 cites
- 1840US10925956B2Methods and compositions for inducing protective immunity against a marburg virus infectionJANSSEN VACCINES & PREVENTION BV·Filed 2017·Granted Feb 23, 2021·0 cites·18 claims
- 1940US10925955B2Methods and compositions for inducing protective immunity against a Marburg virus infectionJANSSEN VACCINES & PREVENTION BV·Filed 2017·Granted Feb 23, 2021·0 cites·5 claims
- 2033US11173204B2MVA-BN and Ad26.ZEBOV or Ad26.filo prime-boost regimenJANSSEN VACCINES & PREVENTION BV·Filed 2018·Granted Nov 16, 2021·0 cites·25 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →